Semavance vs Ozempic: Comparison Guide

Semavance vs Ozempic: A Clear Comparison

Navigating the world of medications for type 2 diabetes and weight management can feel overwhelming. With new options becoming available, it’s natural to have questions. Two names you might hear are Ozempic and Semavance. Both are described as containing the same active ingredient, semaglutide, so the differences are mainly about the manufacturer, device and evidence.

This guide offers a practical, evidence-aware comparison to help you understand the similarities and differences between these two medications. The goal is to provide clear information so you can have more informed conversations with your doctor. Consult your healthcare provider before starting any medication.

Understanding Ozempic (Semaglutide)

Ozempic is Novo Nordisk's brand name for the medication semaglutide. It is an injectable prescription medicine approved for a few key purposes in adults (the second is part of the US label):

• To improve blood sugar control in adults with type 2 diabetes, along with diet and exercise.
• To reduce the risk of major cardiovascular events like heart attack, stroke, or death in adults with type 2 diabetes and known heart disease.

How Ozempic Works

Ozempic belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. In simple terms, it works by mimicking a natural hormone in your body called GLP-1.

When you eat, your body releases GLP-1, which plays a crucial role in managing your blood sugar. Ozempic enhances this natural process in three main ways:

1. It helps your pancreas release more insulin when your blood sugar is high.
2. It prevents your liver from making and releasing too much sugar.
3. It slows down the speed at which food leaves your stomach, which can help you feel full for longer and may reduce your appetite.

This combined action helps control blood sugar levels and often leads to weight loss as a significant additional effect. Ozempic is typically administered as a once-weekly injection using a pre-filled pen.

Understanding Semavance

Semavance is a semaglutide brand name that Medical Dialogues listed in March 2026 among the brands expected from the Indian company Aristo Pharma, after the semaglutide patent expired in India on March 20, 2026. As of October 2026 we could not find an official launch announcement confirming its approved use, strengths or device, so ask your doctor or pharmacist to confirm these from the pack.

How Semavance Works

Semavance is described as containing semaglutide, the same active ingredient as Ozempic. It is a GLP-1 receptor agonist, not a dual GIP/GLP-1 agonist. (The dual GIP/GLP-1 medicine is tirzepatide, sold as Mounjaro, which is a different drug.) It therefore works in the same way as Ozempic: stimulating insulin release when blood sugar is high, reducing sugar production by the liver, slowing digestion and reducing appetite.

Key Similarities Between Semavance and Ozempic

Active Ingredient

Both contain semaglutide, so they are expected to have the same effects and side effects at the same dose.

Method of Administration

Injectable semaglutide is given subcutaneously, meaning just under the skin, usually in the abdomen, thigh, or upper arm, once a week. Indian semaglutide brands come in different formats, including disposable pens, reusable pens, vials and, for some brands, tablets, so check which format Semavance comes in.

Common Side Effects

Because both contain semaglutide, they share the same profile of potential side effects. The most common are gastrointestinal issues, such as:

• Nausea
• Vomiting
• Diarrhoea
• Constipation
• Abdominal pain

These side effects are often mild to moderate and tend to be most noticeable when first starting the medication or after increasing the dose. They typically decrease over time as the body adjusts.

Seek urgent medical help for severe stomach pain that does not go away (it may spread to your back), signs of a serious allergic reaction, or vomiting so much that you cannot keep fluids down. Low blood sugar is more likely if you also take insulin or a sulfonylurea, and people with diabetic eye disease should report any vision changes. Semaglutide is not used in pregnancy, and you should not use it if you or a family member has had medullary thyroid cancer or you have MEN 2. Tell your doctor or anaesthetist that you take it before any surgery or sedation.

Key Differences: A Head-to-Head Look

Manufacturer and Evidence

• Ozempic is made by Novo Nordisk and is backed by large international trials, such as the SUSTAIN programme in type 2 diabetes. In India it was launched in December 2025 for type 2 diabetes, in 0.25 mg, 0.5 mg and 1 mg doses.
• Semavance is listed as an Aristo Pharma brand. Indian semaglutide brands are approved by the Central Drugs Standard Control Organisation (CDSCO); we could not find published trial data specific to Semavance.

Formulation and Dosing

There can be differences in the delivery devices (pens or vials), available strengths and how the dose is set. Your healthcare provider will determine the appropriate starting dose and titration schedule, and will show you how to use the specific product. Do not switch between brands without your doctor.

Making an Informed Decision With Your Doctor

Choosing between medications like Semavance and Ozempic is a decision that is unique to you and should only be made in partnership with a qualified healthcare professional. One is not universally "better" than the other; the best choice depends entirely on your personal health profile.

Here are some factors your provider will consider:

• Your specific health history: This includes your A1C levels, your weight management goals, and any other medical conditions you have, especially a history of pancreatitis or certain thyroid conditions.
• Cardiovascular health: In the US, Ozempic has a specific indication for reducing cardiovascular risk in people with type 2 diabetes and known heart disease. Ask your doctor what the Indian label for each brand covers.
• Your experience with side effects: If you are sensitive to gastrointestinal issues, your doctor may recommend a specific titration schedule or medication.
• Insurance coverage and cost: Practical considerations like what your insurance plan covers can play a significant role in which medication is accessible to you.

Your health journey is your own. This information is intended to be a starting point for a productive, informed conversation with your healthcare team. Consult your healthcare provider before starting any medication.

Ultimately, both Semavance and Ozempic are described as semaglutide products. By understanding their core similarities and key differences, you are better equipped to work with your doctor to find the path that best supports your long-term health.

Sources

• https://www.ozempic.com/
• https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209637s012lbl.pdf
• https://www.niddk.nih.gov/health-information/diabetes/overview/insulin-medicines-treatments
• https://my.clevelandclinic.org/health/treatments/13901-glp-1-agonists
• https://medicaldialogues.in/news/industry/pharma/indias-semaglutide-market-set-for-generic-boom-as-patents-expire-over-50-brands-lined-up-for-launch-see-full-list-165838
• https://www.thenationalnews.com/health/2025/12/12/ozempic-india-weight-loss-drug/
• https://cdsco.gov.in/opencms/opencms/en/Home/